S. Estes

发表

Industry view on the relative importance of "clonality" of biopharmaceutical-producing cell lines.

C. Frye, Karin Anderson, R. Deshpande, 2016, Biologicals : journal of the International Association of Biological Standardization.

Accelerated Clone Selection for Recombinant CHO Cells Using a FACS‐Based High‐Throughput Screen

C. Demaria, S. Estes, V. Cairns, 2007, Biotechnology progress.

Development of a simple and rapid method for producing non‐fucosylated oligomannose containing antibodies with increased effector function

Scott Estes, Qun Zhou, S. Estes, 2008, Biotechnology and bioengineering.

Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives

J. Dumont, S. Estes, R. Kshirsagar, 2015, Critical reviews in biotechnology.

Genetic mutation analysis at early stages of cell line development using next generation sequencing

Joost Groot, S. Estes, C. Wright, 2016, Biotechnology progress.

ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance

R. Moniz, S. Estes, S. Sathyanarayanan, 2021, Communications biology.

Activation of Human Acid Sphingomyelinase through Modification or Deletion of C-terminal Cysteine*

S. M. Van Patten, S. Estes, C. Schwarz, 2003, Journal of Biological Chemistry.

A high‐throughput capillary isoelectric focusing immunoassay for fingerprinting protein sialylation

Young Jun Choi, S. Estes, T. Ryll, 2016, Biotechnology progress.

Leveraging a CHO cell line toolkit to accelerate biotherapeutics into the clinic

S. Estes, C. Wright, R. Kshirsagar, 2017, Biotechnology progress.

Next-generation bioprocess: an industry perspective of how the ‘omics era will affect future biotherapeutic development

S. Estes, C. Wright, Chapman Wright, 2014 .

High‐throughput ion exchange purification of positively charged recombinant protein in the presence of negatively charged dextran sulfate

S. Estes, T. Ryll, John Pieracci, 2014, Biotechnology progress.

Exosome Surface Display of IL12 Results in Tumor-Retained Pharmacology with Superior Potency and Limited Systemic Exposure Compared with Recombinant IL12

S. Estes, S. Sathyanarayanan, A. Boutin, 2020, Molecular Cancer Therapeutics.

Manufactured extracellular vesicles as human therapeutics: challenges, advances, and opportunities.

Jamey D. Young, S. Estes, K. Konstantinov, 2022, Current opinion in biotechnology.

Abstract 944: exoSTING: An engineered exosome therapeutic that selectively delivers STING agonist to the tumor resident antigen-presenting cells resulting in improved tumor antigen-specific adaptive immune response

R. Moniz, S. Estes, S. Sathyanarayanan, 2019, Immunology.

CHO genome mining for synthetic promoter design.

D. James, S. Estes, R. Kshirsagar, 2019, Journal of biotechnology.

A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties

R. Moniz, S. Estes, S. Sathyanarayanan, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

Tumors Associated With Oncogenic Osteomalacia Express Genes Important in Bone and Mineral Metabolism

R. Kumar, P. Manavalan, S. Madden, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Integration of cell line and process development to overcome the challenge of a difficult to express protein

Christina S. Alves, Alan Gilbert, Swati Dalvi, 2015, Biotechnology progress.

Integrated cell and process engineering for improved transient production of a “difficult‐to‐express“ fusion protein by CHO cells

S. Estes, M. Sinacore, Christina S. Alves, 2015, Biotechnology and bioengineering.

709 Exosome surface display of IL-12 results in tumor-retained pharmacology with superior potency and limited systemic exposure

S. Estes, Ke Xu, S. Jang, 2020 .

Mammalian cell line developments in speed and efficiency.

Scott Estes, S. Estes, M. Melville, 2014, Advances in biochemical engineering/biotechnology.

Therapeutic extracellular vesicle production is substantially increased by inhibition of cellular cholesterol biosynthesis.

S. Estes, S. Jang, Chang Ling Sia, 2023, Biotechnology and bioengineering.

Characterization of poloxamers by reversed-phase liquid chromatography

S. Estes, Weiwei Hu, B. Guan, 2016 .

Anoxic induction of a sarcoma virus-related VL30 retrotransposon is mediated by a cis-acting element which binds hypoxia-inducible factor 1 and an anoxia-inducible factor

S. Estes, D. Stoler, G. Anderson, 1995, Journal of virology.

E2F activity is regulated by cell cycle-dependent changes in subcellular localization

K. Moberg, S. Estes, K. Moberg, 1997, Molecular and cellular biology.

Utilization of non‐AUG initiation codons in a flow cytometric method for efficient selection of recombinant cell lines

Scott Estes, C. Demaria, S. Estes, 2011, Biotechnology and bioengineering.

Exosome surface display of IL-12 results in tumor-retained pharmacology with superior potency and limited systemic exposure compared to recombinant IL-12

S. Estes, Sonya Haupt, Chang Ling Sia, 2020 .

Genetic mutation analysis at early stages of cell line development using next generation sequencing

Joost Groot, S. Estes, Chong-feng Xu, 2016, Biotechnology progress (Print).

Normal fibroblasts induce the C/EBP beta and ATF-4 bZIP transcription factors in response to anoxia.

S. Estes, D. Stoler, G. Anderson, 1995, Experimental cell research.